Literature DB >> 16188985

Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.

Sonja M Best1, Keely L Morris, Jeffrey G Shannon, Shelly J Robertson, Dana N Mitzel, Gregory S Park, Elena Boer, James B Wolfinbarger, Marshall E Bloom.   

Abstract

The tick-borne encephalitis (TBE) complex of viruses, genus Flavivirus, can cause severe encephalitis, meningitis, and/or hemorrhagic fevers. Effective interferon (IFN) responses are critical to recovery from infection with flaviviruses, and the mosquito-borne flaviviruses can inhibit this response. However, little is known about interactions between IFN signaling and TBE viruses. Langat virus (LGTV), a member of the TBE complex of viruses, was found to be highly sensitive to the antiviral effects of IFN. However, LGTV infection inhibited IFN-induced expression of a reporter gene driven by either IFN-alpha/beta- or IFN-gamma-responsive promoters. This indicated that LGTV can inhibit the IFN-mediated JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway of signal transduction. The mechanism of inhibition was due to blocks in the phosphorylation of both Janus kinases, Jak1 and Tyk2, during IFN-alpha signaling and at least a failure of Jak1 phosphorylation following IFN-gamma stimulation. To determine the viral protein(s) responsible, we individually expressed all nonstructural (NS) proteins and examined their ability to inhibit signal transduction. Expression of NS5 alone inhibited STAT1 phosphorylation in response to IFN, thus identifying NS5 as a potential IFN antagonist. Examination of interactions between NS5 and cellular proteins revealed that NS5 associated with IFN-alpha/beta and -gamma receptor complexes. Importantly, inhibition of JAK-STAT signaling and NS5-IFN receptor interactions were demonstrated in LGTV-infected human monocyte-derived dendritic cells, important target cells for early virus replication. Because NS5 may interfere with both innate and acquired immune responses to virus infection, this protein may have a significant role in viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188985      PMCID: PMC1235813          DOI: 10.1128/JVI.79.20.12828-12839.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Interferons alpha and beta as immune regulators--a new look.

Authors:  C A Biron
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

Review 2.  Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.

Authors:  Joe F Lau; Curt M Horvath
Journal:  Mt Sinai J Med       Date:  2002-05

Review 3.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

4.  An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization.

Authors:  Marie-Pierre Egloff; Delphine Benarroch; Barbara Selisko; Jean-Louis Romette; Bruno Canard
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

5.  Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.

Authors:  A G Pletnev; M Bray; K A Hanley; J Speicher; R Elkins
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 6.  Immunopathogenesis of dengue virus infection.

Authors:  H Y Lei; T M Yeh; H S Liu; Y S Lin; S H Chen; C C Liu
Journal:  J Biomed Sci       Date:  2001-09       Impact factor: 8.410

Review 7.  Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses.

Authors:  Adolfo García-Sastre
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

8.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

9.  Positional cloning of the murine flavivirus resistance gene.

Authors:  Andrey A Perelygin; Svetlana V Scherbik; Igor B Zhulin; Bronislava M Stockman; Yan Li; Margo A Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-21       Impact factor: 11.205

10.  Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model.

Authors:  Rhea Sumpter; Chunfu Wang; Eileen Foy; Yueh-Ming Loo; Michael Gale
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more
  140 in total

1.  A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis.

Authors:  Dixon Grant; Grace K Tan; Min Qing; Jowin K W Ng; Andy Yip; Gang Zou; Xuping Xie; Zhiming Yuan; Mark J Schreiber; Wouter Schul; Pei-Yong Shi; Sylvie Alonso
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Nonconsensus West Nile virus genomes arising during mosquito infection suppress pathogenesis and modulate virus fitness in vivo.

Authors:  Gregory D Ebel; Kelly A Fitzpatrick; Pei-Yin Lim; Corey J Bennett; Eleanor R Deardorff; Greta V S Jerzak; Laura D Kramer; Yangsheng Zhou; Pei-Yong Shi; Kristen A Bernard
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

4.  Mouse norovirus 1 utilizes the cytoskeleton network to establish localization of the replication complex proximal to the microtubule organizing center.

Authors:  Jennifer L Hyde; Leah K Gillespie; Jason M Mackenzie
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

6.  Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.

Authors:  Junnan Zhang; Jie Shao; Xing Wu; Qunying Mao; Yiping Wang; Fan Gao; Wei Kong; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Hepatitis C virus replication and potential targets for direct-acting agents.

Authors:  Jacqueline G O'Leary; Gary L Davis
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

8.  Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling.

Authors:  Jared D Evans; Christoph Seeger
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Identification of novel small-molecule inhibitors of West Nile virus infection.

Authors:  Amine O Noueiry; Paul D Olivo; Urszula Slomczynska; Yi Zhou; Ben Buscher; Brian Geiss; Michael Engle; Robert M Roth; Kyung Min Chung; Melanie Samuel; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.